Is BMY's Q3 2024 EPS trend sustainable?

**Bristol-Myers Squibb's Q3 2024 EPS trend is not currently forming a sustainable pattern.** Here's an analysis based on the available data:

1. **Recent Performance**: In Q3 2024, Bristol-Myers Squibb experienced a decline in EPS, with a year-over-year growth rate of -0.35%. This negative growth is a red flag for sustainability, as it indicates a potential downturn in profitability.

|code|Ticker|Name|Date|Diluted EPS YoY|market_code|
|---|---|---|---|---|---|
|BMY|BMY.N|Bristol-Myers Squibb|2023 Q4|-8.421052631578943|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q1|-650.4672897196261|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q2|-16.161616161616166|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q3|-35.48387096774194|169|

2. **Quarterly Variations**: The company's EPS has shown a decrease of $0.23 from the previous quarter. This sequential decline suggests that the underlying business issues may be worsening, which is not a sign of sustainability.

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|BMY|BMY.N|Bristol-Myers Squibb|2023 Q4|-8.421052631578943|0.87|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q1|-650.4672897196261|-5.89|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q2|-16.161616161616166|0.83|169|
|BMY|BMY.N|Bristol-Myers Squibb|2024 Q3|-35.48387096774194|0.6|169|

In conclusion, the EPS trend for Bristol-Myers Squibb in Q3 2024 is not sustainable based on the current data. The company's profitability appears to be trending downwards, which could be a cause for concern for investors. However, it's important to note that this is a single quarter's data, and the company's performance may improve in future quarters.